STOCK TITAN

[Form 4] Arteris, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Arteris, Inc. (AIP) – Form 4 insider transaction

Director S. Atiq Raza reported a sale of 1,136 common shares on 18-Jul-2025 at a reported price of $10.00 per share. The disposition was executed under a previously adopted Rule 10b5-1 trading plan dated 6-Jun-2024.

Following the sale, Raza continues to hold a large position: 682,662 shares held indirectly through the Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust and 20,839 shares held directly. The transaction reduced his total ownership by roughly 0.16%, indicating only a marginal change in economic exposure while maintaining significant alignment with shareholders.

Arteris, Inc. (AIP) – Transazione interna Form 4

Il direttore S. Atiq Raza ha comunicato una vendita di 1.136 azioni ordinarie il 18 luglio 2025 al prezzo dichiarato di 10,00 $ per azione. La vendita è stata effettuata nell'ambito di un piano di trading conforme alla Regola 10b5-1 adottato in data 6 giugno 2024.

Dopo la vendita, Raza detiene ancora una posizione significativa: 682.662 azioni detenute indirettamente tramite il Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust e 20.839 azioni detenute direttamente. L’operazione ha ridotto la sua partecipazione totale di circa lo 0,16%, indicando un cambiamento marginale nell’esposizione economica, mantenendo comunque un forte allineamento con gli azionisti.

Arteris, Inc. (AIP) – Transacción interna Formulario 4

El director S. Atiq Raza reportó una venta de 1,136 acciones comunes el 18 de julio de 2025 a un precio reportado de $10.00 por acción. La disposición se ejecutó bajo un plan de trading previamente adoptado conforme a la Regla 10b5-1 con fecha 6 de junio de 2024.

Tras la venta, Raza continúa manteniendo una posición significativa: 682,662 acciones mantenidas indirectamente a través del Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust y 20,839 acciones mantenidas directamente. La transacción redujo su propiedad total en aproximadamente un 0.16%, indicando solo un cambio marginal en la exposición económica mientras mantiene una importante alineación con los accionistas.

Arteris, Inc. (AIP) – Form 4 내부자 거래

이사 S. Atiq Raza는 2025년 7월 18일에 1,136주 보통주 매도를 신고했으며, 신고된 주당 가격은 $10.00입니다. 이 매도는 2024년 6월 6일에 채택된 Rule 10b5-1 거래 계획에 따라 실행되었습니다.

매도 후에도 Raza는 여전히 큰 지분을 보유하고 있습니다: Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust를 통해 간접 보유 682,662주직접 보유 20,839주입니다. 이번 거래로 그의 총 보유 지분은 약 0.16% 감소했으며, 이는 경제적 노출의 미미한 변화를 의미하면서도 주주들과의 강한 연대를 유지함을 나타냅니다.

Arteris, Inc. (AIP) – Transaction d’initié Formulaire 4

Le directeur S. Atiq Raza a déclaré une vente de 1 136 actions ordinaires le 18 juillet 2025 au prix déclaré de 10,00 $ par action. La cession a été réalisée dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 6 juin 2024.

Après la vente, Raza détient toujours une position importante : 682 662 actions détenues indirectement via le Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust et 20 839 actions détenues directement. La transaction a réduit sa participation totale d’environ 0,16 %, indiquant un changement marginal de son exposition économique tout en maintenant un alignement significatif avec les actionnaires.

Arteris, Inc. (AIP) – Insider-Transaktion Form 4

Direktor S. Atiq Raza meldete am 18. Juli 2025 den Verkauf von 1.136 Stammaktien zu einem gemeldeten Preis von 10,00 $ pro Aktie. Die Veräußerung erfolgte im Rahmen eines zuvor am 6. Juni 2024 angenommenen Rule 10b5-1 Handelsplans.

Nach dem Verkauf hält Raza weiterhin eine große Position: 682.662 Aktien indirekt gehalten über den Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust und 20.839 Aktien direkt gehalten. Die Transaktion reduzierte seinen Gesamtbesitz um etwa 0,16%, was nur eine marginale Änderung der wirtschaftlichen Beteiligung darstellt, während er eine bedeutende Ausrichtung mit den Aktionären beibehält.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Minor 1,136-share sale under 10b5-1 plan; ownership essentially unchanged—neutral impact.

The disclosed disposition is small relative to Raza’s 703k-share stake and was pre-scheduled, limiting any signaling value. Ongoing ownership above 680k shares suggests continued commitment. Given the sub-1% size, the filing is not materially impactful to valuation or float dynamics, but investors may note insider liquidity at the $10 level.

Arteris, Inc. (AIP) – Transazione interna Form 4

Il direttore S. Atiq Raza ha comunicato una vendita di 1.136 azioni ordinarie il 18 luglio 2025 al prezzo dichiarato di 10,00 $ per azione. La vendita è stata effettuata nell'ambito di un piano di trading conforme alla Regola 10b5-1 adottato in data 6 giugno 2024.

Dopo la vendita, Raza detiene ancora una posizione significativa: 682.662 azioni detenute indirettamente tramite il Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust e 20.839 azioni detenute direttamente. L’operazione ha ridotto la sua partecipazione totale di circa lo 0,16%, indicando un cambiamento marginale nell’esposizione economica, mantenendo comunque un forte allineamento con gli azionisti.

Arteris, Inc. (AIP) – Transacción interna Formulario 4

El director S. Atiq Raza reportó una venta de 1,136 acciones comunes el 18 de julio de 2025 a un precio reportado de $10.00 por acción. La disposición se ejecutó bajo un plan de trading previamente adoptado conforme a la Regla 10b5-1 con fecha 6 de junio de 2024.

Tras la venta, Raza continúa manteniendo una posición significativa: 682,662 acciones mantenidas indirectamente a través del Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust y 20,839 acciones mantenidas directamente. La transacción redujo su propiedad total en aproximadamente un 0.16%, indicando solo un cambio marginal en la exposición económica mientras mantiene una importante alineación con los accionistas.

Arteris, Inc. (AIP) – Form 4 내부자 거래

이사 S. Atiq Raza는 2025년 7월 18일에 1,136주 보통주 매도를 신고했으며, 신고된 주당 가격은 $10.00입니다. 이 매도는 2024년 6월 6일에 채택된 Rule 10b5-1 거래 계획에 따라 실행되었습니다.

매도 후에도 Raza는 여전히 큰 지분을 보유하고 있습니다: Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust를 통해 간접 보유 682,662주직접 보유 20,839주입니다. 이번 거래로 그의 총 보유 지분은 약 0.16% 감소했으며, 이는 경제적 노출의 미미한 변화를 의미하면서도 주주들과의 강한 연대를 유지함을 나타냅니다.

Arteris, Inc. (AIP) – Transaction d’initié Formulaire 4

Le directeur S. Atiq Raza a déclaré une vente de 1 136 actions ordinaires le 18 juillet 2025 au prix déclaré de 10,00 $ par action. La cession a été réalisée dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 6 juin 2024.

Après la vente, Raza détient toujours une position importante : 682 662 actions détenues indirectement via le Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust et 20 839 actions détenues directement. La transaction a réduit sa participation totale d’environ 0,16 %, indiquant un changement marginal de son exposition économique tout en maintenant un alignement significatif avec les actionnaires.

Arteris, Inc. (AIP) – Insider-Transaktion Form 4

Direktor S. Atiq Raza meldete am 18. Juli 2025 den Verkauf von 1.136 Stammaktien zu einem gemeldeten Preis von 10,00 $ pro Aktie. Die Veräußerung erfolgte im Rahmen eines zuvor am 6. Juni 2024 angenommenen Rule 10b5-1 Handelsplans.

Nach dem Verkauf hält Raza weiterhin eine große Position: 682.662 Aktien indirekt gehalten über den Saiyed Atiq Raza & Nandini Saraiya 2012 Revocable Trust und 20.839 Aktien direkt gehalten. Die Transaktion reduzierte seinen Gesamtbesitz um etwa 0,16%, was nur eine marginale Änderung der wirtschaftlichen Beteiligung darstellt, während er eine bedeutende Ausrichtung mit den Aktionären beibehält.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
RAZA SAIYED ATIQ

(Last) (First) (Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300

(Street)
CAMPBELL CA 95008

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/18/2025 S(1) 1,136 D $10 682,662 I Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012(2)
Common Stock 20,839 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 6, 2024.
2. The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for S. Atiq Raza 07/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Arteris, Inc.

NASDAQ:AIP

AIP Rankings

AIP Latest News

AIP Latest SEC Filings

AIP Stock Data

389.55M
28.69M
33.09%
43.37%
0.82%
Semiconductors
Semiconductors & Related Devices
Link
United States
CAMPBELL